Sumitomo Dainippon Pharma Archives -

A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its

Sumitomo ups ante and wins support for Myovant takeover

https://pharmaphorum.com/news/sumitomo-ups-ante-and-wins-support-for-myovant-takeover/

Exscientia has advanced a drug candidate for Alzheimer’s disease into human testing, the third clinical-stage project for the

Exscientia starts trials of AI-designed Alzheimer’s drug

https://pharmaphorum.com/news/exscientia-starts-clinical-trials-of-ai-designed-alzheimers-drug/

A new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant

Sumitomo, Roivant close $3 billion deal, forming Sumitovant

https://pharmaphorum.com/news/sumitomo-roivant-close-3-billion-deal-forming-sumitovant/

Six weeks after Sumitomo Dainippon Pharma agreed a $3 billion deal to license a host of drug candidates

Sumitomo and Roivant put flesh on bones of $3bn R&D deal

https://pharmaphorum.com/news/sumitomo-and-roivant-put-flesh-on-bones-of-3bn-rd-deal/

Vivek Ramaswamy’s Roivant group has forged its biggest and most wide-ranging alliance to date, licensing dozens of drugs

Sumitomo Dainippon bolts on pipeline via $3bn Roivant alliance

https://pharmaphorum.com/news/sumitomo-dainippon-bolts-on-pipeline-via-3bn-roivant-alliance/

Sumitomo Dainippon Pharma